The anticoagulant dabigatran (Pradaxa) does not appear to cause higher bleeding rates in patients than warfarin, another blood thinning medication, according to an assessment by the U.S. Food and Drug Administration.
FDA safety review: Blood thinner Pradaxa no more likely to cause bleeding than warfarin
Posted in Dental News.
rev="post-1531" No comments
– November 18, 2012
